Jean-Pascal Machiels, MD, PhD
Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Centre du Cancer, Cliniques universitaires Saint-Luc · Cliniques Universitaires SaintLuc, Belgium
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jean-Pascal Machiels, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:51 UTC. Open this list on ClinicalTrials.gov
- N/ANCT03182465 · Predictive Value of ProCalcitonin for the Detection of Bacteraemia in Patients Presenting to the Emergency Department for Low Risk Chemo-induced Febrile NeutropeniaCliniques universitaires Saint-Luc- Université Catholique de Louvain · terminated · Febrile Neutropenia, Drug-Induced · principal investigator
- N/ANCT02572778 · Patient-derived Xenograft Models of Tumor From Patients With Head and Neck CancerCliniques universitaires Saint-Luc- Université Catholique de Louvain · recruiting · Squamous Cell Carcinoma of the Head and Neck · principal investigator
- Ph4NCT02570789 · Evaluation of Predictive Markers for Toxicity and Efficacy in Patients With mccRCC Treated by Anti-VEGF TherapyCliniques universitaires Saint-Luc- Université Catholique de Louvain · terminated · Clear-cell Metastatic Renal Cell Carcinoma · principal investigator
- N/ANCT02139020 · Collection of Plasma Samples for Squamous Cell Carcinoma of the Head and Neck PatientsCliniques universitaires Saint-Luc- Université Catholique de Louvain · recruiting · Squamous Cell Carcinoma of the Head and Neck · principal investigator
- Ph2NCT01856101 · Study of BEZ235 as Monotherapy in Patients With Transitional Cell Carcinoma After Failure of Platinum Based ChemotherapyCliniques universitaires Saint-Luc- Université Catholique de Louvain · terminated · Carcinoma Transitional Cell · principal investigator
- Ph2NCT01528163 · Study Comparing Two Treatments in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCliniques universitaires Saint-Luc- Université Catholique de Louvain · completed · Squamous Cell Carcinoma of the Head and Neck · principal investigator
- Ph1/Ph2NCT01054625 · Zalutumumab Pharmacokinetics (PK) in Squamous Cell Carcinoma of the Head and Neck (SCCHN)Genmab · completed · Head and Neck Cancer · principal investigator
- Ph2NCT00541281 · Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic CancerCliniques universitaires Saint-Luc- Université Catholique de Louvain · completed · Hormone Resistant Prostate Cancer, Metastatic Prostate Cancer
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.